| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 0.956 | 5 | 0 | 1999 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.844 | 2 | 0 | 1994 | 2020 | ||||||||
|
integrin subunit beta 3 | 0.485 | 0.846 | 1.7E-03 |
|
group | 0.590 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.570 | None | 0.889 | 2 | 0 | 1999 | 2019 | ||||||||
|
integrin subunit alpha 2b | 0.493 | 0.692 | 1.5E-16 |
|
group | 0.570 | None | 0.667 | 2 | 0 | 1997 | 2017 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.560 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.500 | None | 0.938 | 12 | 0 | 1997 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
group | 0.500 | None | 0.971 | 11 | 0 | 1995 | 2016 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.500 | None | 1.000 | 4 | 0 | 1989 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
group | 0.500 | None | 0.946 | 4 | 0 | 1995 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.979 | 7 | 0 | 1996 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.400 | None | 0.933 | 6 | 0 | 1998 | 2019 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
group | 0.400 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
group | 0.400 | None | 0.944 | 3 | 0 | 1995 | 2018 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.400 | None | 0.973 | 3 | 0 | 1989 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.400 | None | 0.909 | 2 | 0 | 2000 | 2020 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
group | 0.380 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
fibrinogen alpha chain | 0.573 | 0.769 | 1.2E-13 |
|
group | 0.320 | None | 0.667 | 2 | 0 | 2008 | 2018 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
group | 0.300 | None | 0.953 | 9 | 0 | 2002 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.300 | None | 0.958 | 2 | 0 | 2001 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2019 |